AiCure
PrivateLast Round
VC Round
Jan 23, 2024
Total Funding Raised
$58.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AiCure operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a VC Round in January 2024.
AiCure is a health technology company that provides an AI and advanced data analytics platform to monitor patient behavior and improve clinical trials.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Patient Engagement, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AiCure Comparables
Compare AiCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Datacubed Health | 87% | |
| Koneksa Health | 81% | |
| ObvioHealth | 81% |
For institutional investors. Book with your work email.
AiCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 23, 2024 | ||||
| Series C | Nov 7, 2019 | ||||
| Series B | Nov 17, 2017 | ||||
| Series A | Jan 11, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AiCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series C, Series B, Series A |
| Palisades Growth | Series C |
| NIH RADx | Grant |
| Pritzker Group Venture Capital | Series C, Series A, Series B |
| Biomatics Capital Partners | Series C, Series A, Series B |
| Baird Capital | Series C, Series B |
| SpringRock Ventures | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 199, 510% of current headcount.
- Jul 10, 2025
Monthly visitors increased 576% MoM, reaching 14.2K.
For institutional investors. Book with your work email.
AiCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AiCure's valuation, stock price, and market status.
Is AiCure a public or private company?
AiCure is a private company.
What is the current stock price of AiCure?
AiCure is a private company, so its shares have no public market price. Caplight tracks AiCure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AiCure worth (valuation)?
Valuation information for AiCure is not publicly available.
Can I buy AiCure stock?
AiCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AiCure's last funding round?
AiCure's most recent funding round was VC Round on January 23, 2024.
Who are the main investors in AiCure?
Key investors in AiCure include New Leaf Venture Partners, Palisades Growth, Baird Capital.
Will AiCure IPO soon?
No public IPO plans have been announced for AiCure.
How can I track AiCure secondary market activity?
Caplight tracks bids, offers, and trades in AiCure's shares on secondary markets.